# Economics of Biotech and Medical Innovations

## ECON-4290

Students will learn about markets related to healthcare, insurance, biopharmaceuticals, and medical devices. Examine economic issues, models and quantitative analysis related to firms' activities in areas such as innovation, R&D expenditures, patenting, pricing, mergers and acquisitions, and competition in markets. Examine the role played by health insurance systems. Study the economic implications of regulations, such as those by the U.S. FDA. Economic and policy aspects will be examined within the context of the U.S. healthcare sector, along with selected comparisons to European national healthcare systems.

4 credits
Cross-listed with:
ECON-4290 Economics of Biotech and Medical Innovations ECON-6290 Economics of Biotech and Medical Innovations
Prereqs:
one of:
ECON-1200 Introductory Economics INQR-1200 Principles of Economics INQR-1200 Principles of Economics

# Past Term Data
Offered
Not Offered
Offered as Cross-Listing Only
No Term Data
Simple View
Detailed View

| Spring | Summer | Fall
--- | --- | --- | ---
| (Session 1) | (Session 2) |
2024 | Econ Of Biotech & Med Innov (4c) Vivek Ghosal Seats Taken: 15/19 |  |
2023 |  |  | Econ Of Biotech & Med Innov (4c) Vivek Ghosal Seats Taken: 14/19
2022 | Econ Of Biotech & Med Innov (4c) Vivek Ghosal Seats Taken: 18/19 |  |
2021 | Econ Of Biotech & Med Innov (4c) Vivek Ghosal Seats Taken: 16/19 | Econ Of Biotech & Med Innov (4c) Vivek Ghosal Seats Taken: 18/19 |  | Econ Of Biotech & Med Innov (4c) Vivek Ghosal Seats Taken: 14/19
2020 | Econ Of Biotech & Med Innov (4c) Vivek Ghosal Seats Taken: 16/19 |  |
2019 |  |  |
2018 |  |  |
2017 |  |  |
2016 |  |  |
2015 |  |  |
2014 |  |  |
2013 |  |  |
2012 |  |  |
2011 |  |  |
2010 |  |  |
2009 |  |  |
2008 |  |  |
2007 |  |  |
2006 |  |  |
2005 |  |  |
2004 |  |  |
2003 |  |  |
2002 |  |  |
2001 |  |  |
2000 |  |  |
1999 |  |  |
1998 |  |  |